Online citations, reference lists, and bibliographies.
← Back to Search

Nanotechnology To Improve Oral Drug Delivery

M. Bhavsar, S. Jain, M. Amiji
Published 2008 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1248/BPB.29.1790
Nanocarriers: promising vehicle for bioactive drugs.
M. Rawat (2006)
Nanoparticles and microparticles for drug and vaccine delivery.
J. Kreuter (1996)
10.1016/0168-3659(95)00059-H
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
A. T. Florence (1995)
10.1016/0378-5173(95)04353-5
The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60-nm polystyrene particles after oral administration in the rat
A. M. Hillery (1996)
10.1016/0168-3659(90)90013-J
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
10.1021/bp0342553
Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus
M. Dawson (2004)
10.1615/CRITREVTHERDRUGCARRIERSYST.V23.I4.10
Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives.
M. Nahar (2006)
10.1002/ARDP.19933261202
HIV‐1 Protease Inhibitors: Development, Status, and Potential Role in the Treatment of AIDS
M. Lang (1993)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1016/S0378-5173(01)00829-8
pH-sensitive nanoparticles of poly(amino acid) dodecanoate complexes.
S. General (2001)
[Polymeric nanoparticles: new systems for improving ocular bioavailability of drugs].
M. J. Alonso (2001)
10.1016/S0168-3659(98)00029-7
Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region.
M. Rodríguez (1998)
10.1136/gut.30.4.486
Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease.
C. Seldenrijk (1989)
10.1016/S0168-3659(02)00072-X
Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine.
Shinji Sakuma (2002)
10.1016/S0378-5173(00)00442-7
Polysaccharide coated liposomes for oral immunization--development and characterization.
N. Venkatesan (2000)
10.1016/J.ADDR.2003.12.006
Therapeutic applications of lipid-coated microbubbles.
E. Unger (2004)
10.1016/S0168-3659(98)00108-4
Incorporation of polymeric nanoparticles into solid dosage forms.
C. Schmidt (1999)
10.1016/S0378-5173(02)00461-1
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.
M. H. El-Shabouri (2002)
10.1016/0168-3659(90)90099-F
Polymer structure features contributing to mucoadhesion. II
S. S. Leung (1990)
10.1016/S0169-409X(00)00119-8
Design of nanoparticles composed of graft copolymers for oral peptide delivery.
S. Sakuma (2001)
10.1016/J.JCONREL.2004.03.003
Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
Xue-qing Wang (2004)
10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-#
Insulin‐loaded nanocapsules for oral administration: In vitro and in vivo investigation
M. Aboubakar (2000)
10.1023/A:1013018111829
Gliadin Nanoparticles as Carriers for the Oral Administration of Lipophilic Drugs. Relationships Between Bioadhesion and Pharmacokinetics
M. A. Arangoa (2004)
10.1016/J.JCONREL.2006.05.013
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
F. Cui (2006)
10.1016/J.JCONREL.2006.10.023
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
C. Damgé (2007)
10.1142/9781860949074_0026
Polymeric Nanoparticles for Delivery in the Gastro-Intestinal Tract
M. Bhavsar (2006)
10.1089/10430340460745801
Nonionic polymeric micelles for oral gene delivery in vivo.
Shwu-Fen Chang (2004)
10.1016/S0168-3659(01)00352-2
Nanoparticles of a polyelectrolyte-fatty acid complex: carriers for Q10 and triiodothyronine.
A. Thünemann (2001)
10.1089/0894268041457183
PEG-PLA nanoparticles as carriers for nasal vaccine delivery.
A. Vila (2004)
10.1016/J.IJPHARM.2004.10.003
Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles.
M. S. Mesiha (2005)
Particulate delivery: the challenge of the oral route
A. Florence (1993)
10.1016/S0168-3659(00)00272-8
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state.
F. De Jaeghere (2000)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
ORAL DELIVERY OF INSULIN- MAKING NEEDLES NEEDLESS
R. Narayani (2001)
10.1016/J.JCONREL.2006.08.013
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
10.1211/0022357044210
Oral delivery of spray dried PLGA/amifostine nanoparticles
S. Pamujula (2004)
10.1016/S0378-5173(98)00314-7
Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: modification of the body distribution after suspension in surfactant solutions and in oil vehicles
L. Araujo (1999)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
HIV protease inhibitors: their anti-HIV activity and potential role in treatment.
T. Robins (1993)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1016/S0168-3659(03)00066-X
Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties.
P. Arbós (2003)
10.1016/S0928-0987(00)00198-6
Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.
M. C. Varela (2001)
10.2165/00003088-200241090-00003
Oral Mucosal Drug Delivery
H. Zhang (2002)
10.1016/0169-409X(94)90026-4
Oral cavity as a site for bioadhesive drug delivery
R. Gandhi (1994)
10.1016/J.BIOMATERIALS.2004.07.050
Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
K. Y. Win (2005)
Polymers in Controlled Drug Delivery
L. Illum (1988)
10.1177/00220345870660080201
The Surface Area of the Adult Human Mouth and Thickness of the Salivary Film Covering the Teeth and Oral Mucosa
L. M. Collins (1987)
10.1016/0378-5173(84)90154-6
Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion
K. Park (1984)
10.1081/DDC-100102197
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.
J. Barichello (1999)
10.1016/S0169-409X(98)00040-4
Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.
Ponchel (1998)
Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
C. S. Probert (1996)
10.1023/A:1011063232257
Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice
T. Jung (2004)
10.1016/J.IJPHARM.2004.09.019
Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles.
N. Ubrich (2005)
10.1016/0168-3659(88)90021-1
The contribution of anionic polymer structural features to mucoadhesion
S. S. Leung (1987)
10.1016/S0168-3659(03)00160-3
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Kenji Yamabe (2003)
10.1016/J.BIOENG.2006.05.026
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
D. Emerich (2006)
10.1007/S11894-004-0052-Z
Drug delivery to the small intestine
D. Friend (2004)
10.1023/A:1011032328064
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
A. Lamprecht (2004)
10.1016/J.IJPHARM.2005.01.018
Investigation of lectin-modified insulin liposomes as carriers for oral administration.
N. Zhang (2005)
10.1016/J.IJPHARM.2006.06.040
Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
M. Carafa (2006)
10.1161/HC0202.101988
In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits
Y. Jiao (2002)
10.3748/WJG.V10.I1.112
Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.
J. Chen (2004)
10.1038/7385
Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
K. Roy (1999)
10.3390/10010065
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
F. Delié (2005)
10.1038/sj.clpt.6100400
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
10.1016/S0140-6736(83)92719-8
UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS
J. R. Warren (1983)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/J.JCONREL.2004.03.028
Transdermal delivery of mixnoxidil with block copolymer nanoparticles.
Jongwon Shim (2004)
10.1166/JNN.2006.403
Preparation, characterization and in vivo studies of proliposomes containing Cyclosporine A.
N. Shah (2006)
10.1016/S0378-5173(03)00158-3
Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
H. Li (2003)
10.1016/S0378-5173(01)00985-1
Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres.
Radi Hejazi (2002)
Buccal mucosa as a route for systemic drug delivery: a review.
A. H. Shojaei (1998)
10.1023/A:1020178304031
Biophysical Aspects of Using Liposomes as Delivery Vehicles
A. Ulrich (2002)
10.1016/S0939-6411(03)00155-3
Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.
Sania Mansouri (2004)
10.1016/S0168-3659(99)00247-3
Nanosphere based oral insulin delivery.
G. Carino (2000)
10.3109/03639049809108571
Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.
D. Quintanar-Guerrero (1998)
10.1016/J.IJPHARM.2005.05.032
Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
S. Prabhu (2005)
10.1016/S0169-409X(98)00044-1
The preparation and characterization of polymeric antigen delivery systems for oral administration.
Singh (1998)
10.1038/nrd2197
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
10.1016/S0939-6411(03)00145-0
Development of acrylic-based copolymers for oral insulin delivery.
Aaron C Foss (2004)
10.1208/pt050232
Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model
R. Umamaheshwari (2008)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1046/j.1523-5378.1999.09046.x
Oral Immunization with Helicobacter pylori‐Loaded Poly( d, l‐Lactide‐Co‐Glycolide) Nanoparticles
S. Kim (1999)
10.1146/ANNUREV.BB.09.060180.002343
Comparative properties and methods of preparation of lipid vesicles (liposomes).
F. Szoka (1980)
10.1016/S0378-5173(02)00113-8
Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin.
Shinji Sakuma (2002)
10.1002/JPS.10573
Biodegradable nanoparticles containing protein‐fatty acid complexes for oral delivery of salmon calcitonin
H. Yoo (2004)
10.1002/JBM.B.30156
Novel polyelectrolyte carboxymethyl konjac glucomannan–chitosan nanoparticles for drug delivery. II. Release of albumin in vitro
J. Du (2005)
10.1080/1061186021000054933
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
M. Videira (2002)
10.1016/J.IJPHARM.2005.06.028
Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
H. Takeuchi (2005)
10.1016/S0168-3659(03)00126-3
Chitosan-based gastrointestinal delivery systems.
Radi Hejazi (2003)
10.1016/S0939-6411(00)00084-9
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
10.1016/S0168-3659(02)00238-9
Preparation and evaluation of proliposomes containing salmon calcitonin.
Keon-Hyoung Song (2002)
10.1002/JPS.20750
Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.
F. Cui (2007)
10.1002/JPS.2600810102
Drug delivery via the mucous membranes of the oral cavity.
D. Harris (1992)
10.1016/J.JCONREL.2007.03.006
Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
M. Bhavsar (2007)
10.1016/J.JCONREL.2007.05.019
Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles.
K. Chalasani (2007)
10.1248/BPB.29.1223
Preparation of double liposomes and their efficiency as an oral vaccine carrier.
Shinsuke Ogue (2006)
10.1002/JPS.21183
Past, present, and future technologies for oral delivery of therapeutic proteins.
R. Singh (2008)
10.1016/S0168-3659(02)00239-0
Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.
W. Lee (2002)
10.1016/J.IJPHARM.2003.12.001
Stomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils.
Radi Hejazi (2004)
Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
A. Lamprecht (2001)
10.1136/gut.29.11.1531
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
M. Allison (1988)
10.1080/10611860410001693706
Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting
A. Florence (2004)
10.1016/J.IJPHARM.2004.05.006
pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Jundong Dai (2004)
10.1358/DOF.2002.027.10.740182
Carrier systems for the treatment of inflammatory bowel disease
A. Lamprecht (2002)
10.1016/S0927-7765(99)00157-5
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.
Tobío (2000)
10.1016/J.JCONREL.2006.03.020
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system.
V. Hoffart (2006)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.1016/S0264-410X(96)00149-1
Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
Y. Tabata (1996)
10.1016/S0140-6736(84)91816-6
UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION
B. Marshall (1984)
10.1111/j.2042-7158.1990.tb07033.x
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
Nano and microparticles as controlled drug delivery devices.
Ravi Kumar M.N.V. (2000)
10.1023/A:1012029517394
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
A. Florence (2004)
10.1080/026520400417658
Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization.
J. Molpeceres (2000)
10.1016/S0378-5173(02)00112-6
An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon.
H. Zhang (2002)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar